These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1647169)

  • 21. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression].
    Cubała WJ; Landowski J
    Psychiatr Pol; 2006; 40(3):415-30. PubMed ID: 17037809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid receptor function in major depression.
    Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
    Arch Gen Psychiatry; 2003 Jan; 60(1):24-8. PubMed ID: 12511169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase.
    Hsiung SC; Adlersberg M; Arango V; Mann JJ; Tamir H; Liu KP
    J Neurochem; 2003 Oct; 87(1):182-94. PubMed ID: 12969265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder.
    Lesch KP; Laux G; Schulte HM; Pfüller H; Beckmann H
    Psychiatry Res; 1988 Apr; 24(1):25-34. PubMed ID: 2839859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPA axis dysfunction in major depression: relationship to 5-HT(1A) receptor activity.
    Pitchot W; Herrera C; Ansseau M
    Neuropsychobiology; 2001; 44(2):74-7. PubMed ID: 11490174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid receptors in depression.
    Pariante CM; Nemeroff CB; Miller AH
    Isr J Med Sci; 1995 Dec; 31(12):705-12. PubMed ID: 8543464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic-pituitary-adrenal responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol.
    Hofmann CE; Ellis L; Yu WK; Weinberg J
    Alcohol Clin Exp Res; 2007 Feb; 31(2):345-55. PubMed ID: 17250628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ; Edwards E; Nemeroff CB
    Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness.
    Amsterdam JD; Maislin G; Gold P; Winokur A
    Psychoneuroendocrinology; 1989; 14(1-2):43-62. PubMed ID: 2544002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoids and the genesis of depressive illness. A psychobiological model.
    Dinan TG
    Br J Psychiatry; 1994 Mar; 164(3):365-71. PubMed ID: 7832833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
    Cleare AJ; Forsling M; Bond AJ
    Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells.
    Contesse V; Lefebvre H; Lenglet S; Kuhn JM; Delarue C; Vaudry H
    Can J Physiol Pharmacol; 2000 Dec; 78(12):967-83. PubMed ID: 11149386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: neuroendocrine activity and corticosteroid receptors.
    Reul JM; Rothuizen J; de Kloet ER
    J Steroid Biochem Mol Biol; 1991; 40(1-3):63-9. PubMed ID: 1659883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasopressin as a target for antidepressant development: an assessment of the available evidence.
    Scott LV; Dinan TG
    J Affect Disord; 2002 Nov; 72(2):113-24. PubMed ID: 12200202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The thyroliberin receptor interacts directly with a stimulatory guanine-nucleotide-binding protein in the activation of adenylyl cyclase in GH3 rat pituitary tumour cells. Evidence obtained by the use of antisense RNA inhibition and immunoblocking of the stimulatory guanine-nucleotide-binding protein.
    Paulssen RH; Paulssen EJ; Gautvik KM; Gordeladze JO
    Eur J Biochem; 1992 Feb; 204(1):413-8. PubMed ID: 1310943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
    Maric NP; Adzic M
    Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.